Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Human apotransferrin

EU orphan designation number: EU/3/18/2093   
Active ingredient: Human apotransferrin
Indication: Treatment of beta-thalassaemia intermedia and major
Sponsor: Sanquin Plasma Products B.V.
Plesmanlaan 125, 1066 CX Amsterdam, Nederland

  

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/11/2018 Orphan designation EMA/OD/109/18 (2018)7803 of 19/11/2018